|
|
|
|
|
|
|
Novo Nordisk A/S (NVO)
|
|
47.7067 0.207 (0.44%)
|
09-21 11:50
|
|
Open:
|
47.41
|
Pre. Close:
|
47.5
|
|
High:
|
47.715
|
Low:
|
47.38
|
|
Volume:
|
452,365
|
Market Cap:
|
114820M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
47.681 - 47.997
|
47.997 - 48.282
|
|
Low:
|
46.276 - 46.686
|
46.686 - 47.056
|
|
Close:
|
46.873 - 47.512
|
47.512 - 48.09
|
|
|
|
Technical analysis (as of: 2018-09-21 11:01:14 AM)
|
|
Overall:
|
 
|
|
Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.
|
|
Target:
|
Six months: 56.99 One year: 58.38
|
|
Support:
|
Support1: 46.88 Support2: 39.00
|
|
Resistance:
|
Resistance1:
48.80 Resistance2: 49.98
|
|
Pivot:
|
48.13 
|
|
Moving Averages:
|
MA(5): 47.43 MA(20): 48.51
MA(100): 48.13 MA(250): 49.91
|
|
MACD:
|
MACD(12,26):
-0.35 Signal(12,26,9): -0.22
|
|
%K %D:
|
%K(14,3): 17.51 %D(3): 11.35
|
|
RSI:
|
RSI(14): 42.57
|
|
52-Week:
|
High: 58.37
Low: 44.28 Change(%): -2.5
|
|
Average Vol(K):
|
3-Month: 134096
10-Days 114367
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.NVO has closed above bottom band by 28.0%. Bollinger Bands are 32.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-09-20T09:17:41-04:00
Novo's oral semaglutide successful in late-stage T2D study in Japan; shares up 1% premarket
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
